In a recent prospective study of 1933 pancreatic cysts (251 with surgical histopathology), the combination of MAPK/GNAS and TP53/SMAD4/CTNNB1/mTOR had 88% sensitivity and 98% specificity in diagnosing advanced neoplasia [35]. Here, CTNNB1 is linked to Pancreatic cysts.